| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/09/2006 | US20060052327 Cell specific gene silencing using cell-specific promoters in vitro and in vivo |
| 03/09/2006 | US20060052326 Werner's syndrome helicase as a target for anti -HIV/AIDS therapy |
| 03/09/2006 | US20060052325 Utilization of non-viral sequences for minus-strand DNA transfer and gene reconstitution |
| 03/09/2006 | US20060052324 Methods and compositions for cell activation |
| 03/09/2006 | US20060052323 Method to inhibit cell growth using oligonucleotides |
| 03/09/2006 | US20060052322 Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent |
| 03/09/2006 | US20060052321 Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| 03/09/2006 | US20060052320 Mammalian genes involved in rapamycin resistance and tumorgenesis annexin XIII genes |
| 03/09/2006 | US20060052319 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes |
| 03/09/2006 | US20060052309 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 03/09/2006 | US20060052295 native staphylococcal enterotoxin or streptococcal pyrogenic exotoxin protein, stimulates T cell mitogensis; fusion proteins; carcinomas; combination therapy |
| 03/09/2006 | US20060051869 Transport proteins and their uses |
| 03/09/2006 | US20060051839 DNA expression vectors and methods of use |
| 03/09/2006 | US20060051819 Detection, evaluation and treatment for advanced prostate cancer |
| 03/09/2006 | US20060051757 Diagnostic and therapeutic use of ensadin-0477 gene and protein for neurodegenerative diseases |
| 03/09/2006 | US20060051743 Screening nucleic acid comprising sequence that encodes reverse transciptase domain of DNA polymerase for adefovir-resistant mutations; use in vaccine development |
| 03/09/2006 | US20060051426 Nanoparticles containing polymeric nucleic acid homologs pharmaceutical composition and articles of manufacture containing same and methods of use thereof |
| 03/09/2006 | US20060051424 Compositions of oral gene therapy and methods of using same |
| 03/09/2006 | US20060051405 Compositions for the delivery of therapeutic agents and uses thereof |
| 03/09/2006 | US20060051380 Methods and compositions for the targeting of a systemic immune response to specific organs or tissues |
| 03/09/2006 | US20060051370 Microorganisms for therapy |
| 03/09/2006 | US20060051351 ErbB4 receptor-specific neuregulin related ligands and uses therefor |
| 03/09/2006 | US20060051335 fusing cells: nucleic acid vector comprises a nucleotide sequence encoding a syncytium-inducing polypeptide that is expressible on a eukaryotic cell surface and comprises a sequence of a gibbon ape leukemia virus |
| 03/09/2006 | US20060051334 Injection of bone marrow-derived conditioned medium for angiogenesis |
| 03/09/2006 | US20060051333 AAV virions with decreased immunoreactivity and uses therefor |
| 03/09/2006 | US20060051332 Generation of histocompatible tissues using nuclear transplantation |
| 03/09/2006 | US20060051331 Optimization of transgene expression in mammalian cells |
| 03/09/2006 | US20060051330 Method for carrying out the ex vivo expansion and ex vivo differentiation of multipotent stem cells |
| 03/09/2006 | US20060051322 Method for therapy of neurodegenerative disease of the brain |
| 03/09/2006 | DE102004042546A1 Kombinationstherapie zur Immunstimulation Combination therapy for immune stimulation |
| 03/09/2006 | DE10108412B4 Pigmentepithelzelle des Auges, ihre Herstellung und Verwendung in der Therapie einer Augen- oder Nervenerkrankung Pigment epithelial cell of the eye, their preparation and use in the therapy of a nervous disease or eye |
| 03/09/2006 | DE10019195B4 Reversible Immortalisierung Reversible immortalization |
| 03/09/2006 | CA2594672A1 Methods and compositions to inhibit p2x7 receptor expression |
| 03/09/2006 | CA2570735A1 Treatment of hiv infection by t-cell modulation |
| 03/08/2006 | EP1632571A1 Human artificial chromosome containing human antibody Lambda light chain and non-human animal containing the human artificial chromosome capable of genetic transmission |
| 03/08/2006 | EP1632499A2 Gene sequences amplified in tumours and their diagnostic uses |
| 03/08/2006 | EP1632248A1 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness |
| 03/08/2006 | EP1632242A2 Novel method for down-regulation of amyloid |
| 03/08/2006 | EP1632238A1 Encapsulated cells adapted for implantation into the aqueous and vitreous humor of the eye |
| 03/08/2006 | EP1631823A2 NOVEL REGULATORY MECHANISMS OF NF-kappaB |
| 03/08/2006 | EP1631674A2 Peptide ligands of dendritic cells for nucleic acid vector targeting |
| 03/08/2006 | EP1631673A2 Recombinant influenza vectors with a polii promoter and ribozymes |
| 03/08/2006 | EP1631672A1 Circular expression construct for gene therapeutic applications |
| 03/08/2006 | EP1631670A2 Conserved hbv and hcv sequences useful for gene silencing |
| 03/08/2006 | EP1631576A2 Stabilized immunomodulatory oligonucleotides |
| 03/08/2006 | EP1631319A2 In vivo production of a clostridial neurotoxin light chain peptide |
| 03/08/2006 | EP1631281A2 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit |
| 03/08/2006 | EP1631237A2 Proteoglycan degrading mutants for treatment of cns |
| 03/08/2006 | EP1631235A2 Compositions and methods for the modulation of the expression of b7 protein |
| 03/08/2006 | EP1472290A4 Cyclodextrin grafted biocompatible amphiphilic polymer and methods of preparation and use thereof |
| 03/08/2006 | EP1429689A4 Rational drug therapy device and methods |
| 03/08/2006 | EP1278770B1 Human wingless-like gene |
| 03/08/2006 | EP1257581B1 Compounds related to or derived from gfr alpha 4 and their use |
| 03/08/2006 | EP1238086B1 Vaccine for enhancing immune responses to herpes simplex virus |
| 03/08/2006 | EP1237565B1 Betaglycan as an inhibin receptor and uses thereof |
| 03/08/2006 | EP1230338B1 Continuous-flow method for preparing microparticles |
| 03/08/2006 | EP1204744B1 Isolated peptide of the horny layer and use thereof |
| 03/08/2006 | EP1185659B1 Dna pcv vaccine |
| 03/08/2006 | EP1151082B1 Sebocytes, sebocyte cell lines and applications thereof |
| 03/08/2006 | EP1123396B1 Minimal promoters and uses thereof |
| 03/08/2006 | EP1079806B1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear |
| 03/08/2006 | EP1076694B1 Methods and substances for preventing and treating autoimmune disease |
| 03/08/2006 | EP1038011B1 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
| 03/08/2006 | EP1032662B1 Methods and compositions for immunomodulation |
| 03/08/2006 | EP0910628B1 Inactivation resistant factor viii |
| 03/08/2006 | EP0841941B1 Novel non-pyrogenic bacterial strains and use of the same |
| 03/08/2006 | EP0659216B1 Retroviral vector for the transfer and expression of genes for therapeutical purposes in eucaryotic cells |
| 03/08/2006 | CN1745100A 因子Ⅷ多肽 Ⅷ factor polypeptides |
| 03/08/2006 | CN1744919A Method and composition for treating tumors by selective induction of apoptosis |
| 03/08/2006 | CN1744910A Drugs containing galectin 9 |
| 03/08/2006 | CN1744823A Engineering three-dimensional tissue structures using differentiating embryonic stem cells |
| 03/08/2006 | CN1744821A Methods and compositions using compounds from fetal cells and tissues to improve condition of skin |
| 03/08/2006 | CN1744814A Method of producing recombinant proteins in the mammary gland of non-transgenic mammals |
| 03/08/2006 | CN1742997A Mimetics of interleukin-8 and use of them in the prevention, treatment, diagnosis of a disease |
| 03/08/2006 | CN1244698C Expression of recombination SARS virus gene in polymorphic Hansen yeast and its use |
| 03/07/2006 | US7008921 Materials and methods relating to endothelial cell growth inhibitors |
| 03/07/2006 | US7008791 Liposome-entrapped DNA oral vaccines |
| 03/07/2006 | US7008779 novel gene and protein designated PHELIX; in normal individuals, expressed only in testis, but expressed at high levels in advanced and metastatic prostate cancer, and expressed at lower levels in testicular, bladder, ovarian cancers |
| 03/07/2006 | US7008765 polynucleotides that code for prostate specific antigen proteins or polypeptides; cells containing the recombinant nucleic acid molecules; hybridomas containing the antibodies; kits containing probes or antibodies; prevention of prostate cancer |
| 03/07/2006 | US7008643 Delivery system for biological material |
| 03/07/2006 | US7008642 allow delivery of a therapeutic substance to a diseased region without significant loss from blood or other fuild flow; simultaneous treatment of multiple regions of a particular lumen or network of lumens |
| 03/07/2006 | US7008633 Injection of a biocompatible polymer, polysaccharide or polyamino acid, a cross-linker, and therapeutic agent into tumor; hydrogel formed in the tumor retains the therapeutic agent |
| 03/02/2006 | WO2006023848A2 Rna interference vectors |
| 03/02/2006 | WO2006023654A2 Awat-related methods and articles |
| 03/02/2006 | WO2006023544A2 Therapeutic uses of inhibitors of rtp801 |
| 03/02/2006 | WO2006023491A2 Method of delivering rna interference and uses thereof |
| 03/02/2006 | WO2006022887A1 Nanocoating for improving biocompatibility of medical implants |
| 03/02/2006 | WO2006022422A1 Modified human hepatitis c virus genomic rna having autonomous replicative competence |
| 03/02/2006 | WO2006022344A1 Utilization of anti-mortalin 2 antibody and functional nucleic acid in treating cancer |
| 03/02/2006 | WO2006022249A1 Target nucleic acid of retrovirus integration |
| 03/02/2006 | WO2006021724A2 Adeno-associated viral vector for exon skipping in a gene encoding a dispensable-domain protein |
| 03/02/2006 | WO2005113018A3 Cancer treatment using viruses and camptothecins |
| 03/02/2006 | WO2005110492A3 Method of using adenoviral vectors to induce an immune response |
| 03/02/2006 | WO2005105136A9 Nanogene therapy for cell proliferation disorders |
| 03/02/2006 | WO2005084714A3 Raav-neprilysin compositions and methods of use |
| 03/02/2006 | WO2005072088A3 Immunotherapy compositions, method of making and method of use thereof |
| 03/02/2006 | WO2005049630A3 Antisense modulation of kinesin-like 1 expression |
| 03/02/2006 | WO2005045036A3 Rna interference mediated inhibition of hairless (hr) gene expression using short interfering nucleic acid (sina) |
| 03/02/2006 | WO2005013901A3 Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
| 03/02/2006 | WO2004078950A3 METHODS AND COMPOSITIONS FOR SELECTIVE RNAi MEDIATED INHIBITION OF GENE EXPRESSION IN MAMMAL CELLS |